Aqr Capital Management LLC Cyclerion Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.69 - $5.12 $167,468 - $318,750	-62,256 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.25 - $7.12 $140,076 - $443,262	62,256 New	62,256 $191,000
Q3 2020 Nov 16, 2020	SELL	$3.46 - $8.39 $272,641 - $661,115	-78,798 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$2.37 - $7.14 $199,279 - $600,359	-84,084 Reduced 51.62%	78,798 $466,000
Q1 2020 May 15, 2020	BUY	$2.46 - $5.84 $38,189 - $90,660	15,524 Added 10.53%	162,882 $432,000
Q4 2019 Feb 14, 2020	BUY	$1.8 - $13.43 $265,244 - $1.98 Million	147,358 New	147,358 $401,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $145M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.